Clinical Trial Update: An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation [Phase 3]

View source ↗

Summary

An open-label, long-term safety study evaluating linaclotide in patients with chronic constipation or irritable bowel syndrome with constipation has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

Sponsor: Forest Laboratories | Conditions: Chronic Constipation, Irritable Bowel Syndrome With Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-02-15